Main Article Content
World Health Organization. World Health Assembly agrees global malaria strategy and programme budget 2016-17. Geneva: World Health Organization;2015.
Mayo CW, Brady FJ. The eighth world health assembly. Public Health Rep 1955;70:1057-60.
Kusriastuti R, Surya A. New treatment policy of malaria as a part of malaria control program in Indonesia. Acta Med Indones 2012;44:265-9.
The PATH Malaria Vaccine Initiative (MVI). Fact sheet: The RTS,S malaria vaccine candidate (MosquirixTM);2015.
The RTS,S Clinical Trials Partnership. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 2012;367:2284-95. DOI: 10.1056/NEJMoa1208394.
RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 2015;386:31-45.
Glaxo Smith Kline Biologicals and PATH Malaria Vaccine Initiative. RTS,S/AS01 candidate malaria vaccine-summary for the SAGE meeting;2009.
Stoute JA, Kester KE, Krzych U, et al. Longterm efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis 1998;178:1139-44.